Alzamend Neuro, Inc. (ALZN)
1.66
-0.02
(-1.19%)
USD |
NASDAQ |
Sep 09, 10:53
Alzamend Neuro Total Assets (Quarterly) : 2.079M for April 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 2.079M |
| January 31, 2026 | 4.042M |
| October 31, 2025 | 5.092M |
| July 31, 2025 | 6.327M |
| April 30, 2025 | 4.603M |
| January 31, 2025 | 4.176M |
| October 31, 2024 | 5.008M |
| July 31, 2024 | 1.670M |
| April 30, 2024 | 0.6316M |
| January 31, 2024 | 0.8526M |
| Date | Value |
|---|---|
| October 31, 2023 | 0.9836M |
| July 31, 2023 | 2.628M |
| April 30, 2023 | 5.916M |
| January 31, 2023 | 8.502M |
| October 31, 2022 | 10.42M |
| July 31, 2022 | 12.21M |
| April 30, 2022 | 14.52M |
| January 31, 2022 | 12.43M |
| October 31, 2021 | 14.50M |
| July 31, 2021 | 16.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.346M |
| Shareholders Equity (Quarterly) | 0.7332M |
| Current Ratio | 1.311 |